Anesthesiology, Pain Medicine · Huntsville, AL
NPI
1962564476
Since 2006
Specialty
Anesthesiology, Pain Medicine
Code 207LP2900X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
185 Chateau Drive, Suite 302
Huntsville, AL, 35801
Phone (256) 885-1605
Groups this clinician bills Medicare through
Medicare paid, 2024
$148K
6,313 services
Medicare patients, 2024
196
Average age 66
Drug cost, 2024
$855K
10,847 prescriptions
Company payments, 2025
$4,700
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James D Thacker Jr. was code 99214 (office e&m - established), 1,614 times for 188 patients. In total James D Thacker Jr. billed 6,313 services in 31 codes, and Medicare paid $148K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-02-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,614 | 188 | $79.18 | $128K |
| 96146 Behavioral Health Services | Office | 901 | 160 | $1.35 | $1,215 |
| 11105 Skin Biopsy | Office | 42 | 11 | $37.33 | $1,568 |
| 20561 Electrical Nerve Conductivity | Office | 34 | 18 | $24.24 | $824 |
| 96372 Injection Administration | Office | 34 | 24 | $9.05 | $308 |
| 99204 Office E&M - New | Office | 33 | 33 | $97.04 | $3,202 |
| 80305 Drug Tests | Office | 25 | 19 | $11.45 | $286 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 15 | 13 | $0.94 | $14.13 |
| 11104 Skin Biopsy | Office | 14 | 11 | $79.12 | $1,108 |
By year: 2022 $136K for 2,490 services; 2023 $117K for 3,946 services; 2024 $148K for 6,313 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80305 Drug Tests | 25 | 19 | $11.45 | $286 |
Medicare prescription drug claims, 2024
In 2024, the drug James D Thacker Jr. prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 1,257 prescriptions and refills. In total James D Thacker Jr. wrote 10,847 Medicare prescriptions that cost $855K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 1,257 | 1,260 | 142 | $40K |
| Gabapentin Generic | 1,066 | 1,089 | 108 | $14K |
| Oxycodone Hcl Generic | 1,026 | 1,026 | 108 | $22K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 981 | 983 | 116 | $33K |
| Tizanidine Hcl Generic | 735 | 747 | 80 | $12K |
| Pregabalin Generic | 574 | 593 | 66 | $17K |
| Morphine Sulfate Er Morphine Sulfate | 570 | 570 | 53 | $17K |
| Cyclobenzaprine Hcl Generic | 417 | 435 | 50 | $5,839 |
| Meloxicam Generic | 346 | 354 | 54 | $878 |
| Baclofen Generic | 313 | 321 | 34 | $3,844 |
| Methocarbamol Generic | 265 | 265 | 39 | $3,766 |
| Hydromorphone Hcl Generic | 258 | 258 | 39 | $8,365 |
| Tramadol Hcl Generic | 257 | 257 | 37 | $3,193 |
| Xtampza Er Oxycodone Myristate | 217 | 217 | 18 | $143K |
| Diclofenac Sodium Generic | 190 | 194 | 33 | $5,477 |
Brand drugs: 824 claims; generic drugs: 9,983 claims; opioid claims: 4,906.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James D Thacker Jr. $4,700 ($4,100 in general payments such as food, travel and fees and $600 for research) from 8 companies. The largest payer was Atland Pharmaceuticals, LLC with $4,129.
| Company | Payments | Amount |
|---|---|---|
| Atland Pharmaceuticals, LLC | 3 | $4,129 |
| Indivior Inc. INDV | 3 | $192 |
| Inspire Medical Systems, Inc. INSP | 1 | $109 |
| Collegium Pharmaceutical, Inc. COLL | 6 | $108 |
| Scilex Pharmaceuticals Inc. | 3 | $56.42 |
| Protega Pharmaceutials Inc | 3 | $50.24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $34.52 |
| Virtus Pharmaceuticals LLC | 1 | $21.77 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.